Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Neuropsychiatry Clin Neurosci ; 33(4): 314-320, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34213980

RESUMEN

OBJECTIVE: Deep brain stimulation (DBS) is an effective surgical treatment for patients with Parkinson's disease (PD). DBS therapy, particularly with the subthalamic nucleus (STN) target, has been linked to rare psychiatric complications, including depression, impulsivity, irritability, and suicidality. Stimulation-induced elevated mood states can also occur. These episodes rarely meet DSM-5 criteria for mania or hypomania. METHODS: The investigators conducted a chart review of 82 patients with PD treated with DBS. RESULTS: Nine (11%) patients developed stimulation-induced elevated mood. Five illustrative cases are described (all males with STN DBS; mean age=62.2 years [SD=10.5], mean PD duration=8.6 years [SD=1.6]). Elevated mood states occurred during or shortly after programming changes, when more ventral contacts were used (typically in monopolar mode) and lasted minutes to months. Four patients experienced elevated mood at low amplitudes (1.0 V/1.0 mA); all had psychiatric risk factors (history of impulse-control disorder, dopamine dysregulation syndrome, substance use disorder, and/or bipolar diathesis) that likely contributed to mood destabilization. CONCLUSIONS: Preoperative DBS evaluations should include a thorough assessment of psychiatric risk factors. The term "stimulation-induced elevated mood states" is proposed to describe episodes of elevated, expansive, or irritable mood and psychomotor agitation that occur during or shortly after DBS programming changes and may be associated with increased goal-directed activity, impulsivity, grandiosity, pressured speech, flight of ideas, or decreased need for sleep and may persist beyond stimulation adjustments. This clinical phenomenon should be considered for inclusion in the bipolar disorder category in future DSM revisions, allowing for increased recognition and appropriate management.


Asunto(s)
Trastorno Bipolar/diagnóstico , Estimulación Encefálica Profunda/efectos adversos , Trastornos Disruptivos, del Control de Impulso y de la Conducta/diagnóstico , Trastornos del Humor/diagnóstico , Enfermedad de Parkinson/complicaciones , Anciano , Trastorno Bipolar/etiología , Trastornos Disruptivos, del Control de Impulso y de la Conducta/etiología , Humanos , Conducta Impulsiva , Masculino , Manía , Persona de Mediana Edad , Trastornos del Humor/etiología , Núcleo Subtalámico , Resultado del Tratamiento
2.
J Neurosci ; 29(5): 1312-8, 2009 Feb 04.
Artículo en Inglés | MEDLINE | ID: mdl-19193878

RESUMEN

Oxytocin receptors in the nucleus accumbens have been implicated in the regulation of alloparental behavior and pair bond formation in the socially monogamous prairie vole. Oxytocin receptor density in the nucleus accumbens is positively correlated with alloparenting in juvenile and adult female prairie voles, and oxytocin receptor antagonist infused into the nucleus accumbens blocks this behavior. Furthermore, prairie voles have higher densities of oxytocin receptors in the accumbens than nonmonogamous rodent species, and blocking accumbal oxytocin receptors prevents mating-induced partner preference formation. Here we used adeno-associated viral vector gene transfer to examine the functional relationship between accumbal oxytocin receptor density and social behavior in prairie and meadow voles. Adult female prairie voles that overexpress oxytocin receptor in the nucleus accumbens displayed accelerated partner preference formation after cohabitation with a male, but did not display enhanced alloparental behavior. However, partner preference was not facilitated in nonmonogamous meadow voles by introducing oxytocin receptor into the nucleus accumbens. These data confirm a role for oxytocin receptor in the accumbens in the regulation of partner preferences in female prairie voles, and suggest that oxytocin receptor expression in the accumbens is not sufficient to promote partner preferences in nonmonogamous species. These data are the first to demonstrate a direct relationship between oxytocin receptor density in the nucleus accumbens and variation in social attachment behaviors. Thus, individual variation in oxytocin receptor expression in the striatum may contribute to natural diversity in social behaviors.


Asunto(s)
Arvicolinae/fisiología , Núcleo Accumbens/metabolismo , Receptores de Oxitocina/metabolismo , Conducta Sexual Animal/fisiología , Conducta Social , Animales , Femenino , Masculino , Preferencia en el Apareamiento Animal/fisiología , Núcleo Accumbens/química , Núcleo Accumbens/fisiología , Apareamiento , Receptores de Oxitocina/fisiología
3.
Toxins (Basel) ; 12(5)2020 05 17.
Artículo en Inglés | MEDLINE | ID: mdl-32429600

RESUMEN

In 2016, the American Academy of Neurology (AAN) published practice guidelines for botulinum toxin (BoNT) in the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. This article, focusing on dystonia, provides context for these guidelines through literature review. Studies that led to Food and Drug Administration (FDA) approval of each toxin for dystonia indications are reviewed, in addition to several studies highlighted by the AAN guidelines. The AAN guidelines for the use of BoNT in dystonia are compared with those of the European Federation of the Neurological Societies (EFNS), and common off-label uses for BoNT in dystonia are discussed. Toxins not currently FDA-approved for the treatment of dystonia are additionally reviewed. In the future, additional toxins may become FDA-approved for the treatment of dystonia given expanding research in this area.


Asunto(s)
Inhibidores de la Liberación de Acetilcolina/uso terapéutico , Toxinas Botulínicas/uso terapéutico , Aprobación de Drogas , Distonía/tratamiento farmacológico , Guías de Práctica Clínica como Asunto/normas , United States Food and Drug Administration/normas , Inhibidores de la Liberación de Acetilcolina/efectos adversos , Toxinas Botulínicas/efectos adversos , Consenso , Composición de Medicamentos , Humanos , Uso Fuera de lo Indicado , Estados Unidos
4.
Neuropsychopharmacology ; 36(11): 2200-10, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21734650

RESUMEN

Despite significant evidence that opioids are involved in attachment by mediating social reward and motivation, the role of opioids in the formation of adult social attachments has not been explored. We used the socially monogamous prairie vole (Microtus ochrogaster) to explore the role of endogenous opioids in social bonding by examining partner preference formation in female prairie voles. We hypothesized that µ-opioid receptors (MORs) in the striatum have a critical role in partner preference formation. We therefore predicted that peripheral administration of an opioid receptor antagonist would inhibit partner preference formation, and more specifically, that µ-opioid selective receptor blockade within the striatum would inhibit partner preference formation. To test our hypotheses, we first administered the non-selective opioid antagonist naltrexone peripherally to females during an 18-h cohabitation with a male and later tested the female with a partner preference test (PPT). Females showed a dose schedule-dependent decrease in partner preference in the PPT, with females in the continuous dose group displaying stranger preferences. Next, we administered microinjections of the MOR selective antagonist D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP) into either the nucleus accumbens shell (NAS) or the caudate-putamen (CP) immediately before a 24-h cohabitation with a male, and later tested the female with a PPT. Females receiving CTAP into the CP, but not the NAS, showed no preference in the PPT, indicating an inhibition of partner preference formation. We show here for the first time that MORs modulate partner preference formation in female prairie voles by acting in the CP.


Asunto(s)
Cuerpo Estriado/metabolismo , Apareamiento , Receptores Opioides mu/metabolismo , Conducta Sexual Animal/fisiología , Conducta Social , Factores de Edad , Animales , Arvicolinae , Cuerpo Estriado/efectos de los fármacos , Femenino , Masculino , Microinyecciones , Naltrexona/administración & dosificación , Péptidos Opioides/administración & dosificación , Receptores Opioides mu/antagonistas & inhibidores , Receptores Opioides mu/fisiología , Conducta Sexual Animal/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA